Immunic to participate in investor and scientific conferences in august

New york , aug. 1, 2023 /prnewswire/ -- immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in august: august 8-9: 2023 wedbush pacgrow healthcare conference. daniel vitt, ph.d.
IMUX Ratings Summary
IMUX Quant Ranking